Patent · US Active

Fusion molecules and IL-15 variants

US8163879B2 · kind B2 · utility

62Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2010
Grant dateApr 24, 2012
Priority date
Expiry dateFeb 5, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P21/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The instant invention provides soluble fusion protein complexes and IL-15 variants that have therapeutic and diagnostic use, and methods for making the such proteins. The instant invention additionally provides methods of stimulating or suppressing immune responses in a mammal using the fusion protein complexes and IL-15 variants of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.